ON-THE-SPOT MAINTENANCE

FOR VARIOUS TYPES OF DERMATOSES

GOES TO WORK DAILY

ON SKIN RELIEF AND RESTORATION
Reduces symptoms, repairs the skin barrier, and soothes flares associated with various types of dermatoses1-3

ADVANCED TECHNOLOGY

FOR COMFORTABLE PROTECTION

Cosmetically elegant formulation, no allergens, irritants, or steroids1,4

EQUIPS PATIENTS ON THE MOVE

DURING PEAK SEASON

Convenient 100 gram tube for on-the-spot protection year-round1

STANDS UP TO THE TEST

IN 2 STUDIES

Dramatic improvement in atopic symptoms clinically demonstrated in patients with atopic dermatitis2,3

With the Eletone savings card, eligible patients may save on their prescription.
Terms and conditions apply.

ELETONE® CLEARS THE WAY FOR

ATOPIC SKIN REPAIR.

Eletone is a nonsteroidal barrier cream that is designed to protect the skin of people with mild-to-moderate atopic dermatitis, a condition that is often marked by dry, flaky, itchy skin.

  • NO harsh preservatives
  • NO fragrance added
  • Non-greasy

With its unique delivery system, Eletone provides a high-lipid formulation that goes on with the elegance of a cream.

In addition, Eletone does not contain the harsh preservatives found in many other barrier protection products and is completely free of ethanol and isopropyl alcohol, which can actually make skin drier. And, because Eletone is fragrance-free and isn’t greasy, it can be a great treatment for atopic dermatitis in children and adults alike!

References:

1. Eletone [package insert]. San Antonio, TX: Mission Pharmacal Company.

2. Emer JJ, Frankel A, Sohn A, Lebwohl M. A bilateral comparison of pimecrolimus cream 1% and a topical medical device cream in the treatment of patients with atopic dermatitis. J Drugs Dermatol. 2011; 10(7): 735-743.

3. Abramovits W, Oquendo M. Hydrocortisone butyrate 0.1% lipocream in pediatric patients with atopic dermatitis. Skinmed. 2010; 8(2): 72- 79.

4. Kircik LH. Managing atopic dermatitis in children: the role of newer nonsteroidal topical treatments. Skin & Allergy News. 2007; (suppl): 1-4.